<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd"><id>2938470</id><setSpec>journal_article</setSpec><setSpec>doc-type:article</setSpec><setSpec>ddc:570</setSpec><setSpec>journal_articleFtxt</setSpec><setSpec>open_access</setSpec>

<genre>article</genre>

<titleInfo><title>Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein</title></titleInfo>


<note type="publicationStatus">published</note>


<note type="qualityControlled">yes</note>

<name type="personal">
  <namePart type="given">Nadja Alina</namePart>
  <namePart type="family">Henke</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">62867163</identifier></name>
<name type="personal">
  <namePart type="given">Volker F.</namePart>
  <namePart type="family">Wendisch</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">15282606</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0003-3473-0012</description></name>







<name type="corporate">
  <namePart/>
  <identifier type="local">2685319</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>

<name type="corporate">
  <namePart/>
  <identifier type="local">33070705</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>








<abstract lang="eng">Astaxanthin is one of the strongest natural antioxidants and a red pigment occurring in nature. This C40 carotenoid is used in a broad range of applications such as a colorant in the feed industry, an antioxidant in cosmetics or as a supplement in human nutrition. Natural astaxanthin is on the rise and, hence, alternative production systems are needed. The natural carotenoid producer Corynebacterium glutamicum is a potent host for industrial fermentations, such as million-ton scale amino acid production. In C. glutamicum, astaxanthin production was established through heterologous overproduction of the cytosolic lycopene cyclase CrtY and the membrane-bound β-carotene hydroxylase and ketolase, CrtZ and CrtW, in previous studies. In this work, further metabolic engineering strategies revealed that the potential of this GRAS organism for astaxanthin production is not fully exploited yet. It was shown that the construction of a fusion protein comprising the membrane-bound β-carotene hydroxylase and ketolase (CrtZ~W) significantly increased astaxanthin production under high glucose concentration. An evaluation of used carbon sources indicated that a combination of glucose and acetate facilitated astaxanthin production. Moreover, additional overproduction of cytosolic carotenogenic enzymes increased the production of this high value compound. Taken together, a seven-fold improvement of astaxanthin production was achieved with 3.1 mg/g CDW of astaxanthin. </abstract>

<relatedItem type="constituent">
  <location>
    <url displayLabel="marinedrugs-17-00621.wendisch.pdf">https://pub.uni-bielefeld.de/download/2938470/2938564/marinedrugs-17-00621.wendisch.pdf</url>
  </location>
  <physicalDescription><internetMediaType>application/pdf</internetMediaType></physicalDescription>
  <accessCondition type="restrictionOnAccess">no</accessCondition>
</relatedItem>
<originInfo><publisher>MDPI</publisher><dateIssued encoding="w3cdtf">2019</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>

<subject><topic>astaxanthin</topic><topic>Corynebacterium glutamicum</topic><topic>fusion protein</topic><topic>β-carotene ketolase</topic><topic>β-carotene hydroxylase</topic>
</subject>


<relatedItem type="host"><titleInfo><title>Marine Drugs</title></titleInfo>
  <identifier type="issn">1660-3397</identifier>
  <identifier type="eIssn">1660-3397</identifier>
  <identifier type="MEDLINE">31683510</identifier>
  <identifier type="ISI">000502262200011</identifier><identifier type="urn">urn:nbn:de:0070-pub-29384705</identifier><identifier type="doi">10.3390/md17110621</identifier>
<part><detail type="volume"><number>17</number></detail><detail type="issue"><number>11</number></detail>
</part>
</relatedItem>


<extension>
<bibliographicCitation>
<ieee> N.A. Henke and V.F. Wendisch, “Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein”, &lt;em&gt;Marine Drugs&lt;/em&gt;,  vol. 17, 2019, : 621.</ieee>
<harvard1>Henke, N.A., &amp;amp; Wendisch, V.F., 2019. Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein. &lt;em&gt;Marine Drugs&lt;/em&gt;, 17(11): 621.</harvard1>
<apa>Henke, N. A., &amp;amp; Wendisch, V. F. (2019). Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein. &lt;em&gt;Marine Drugs&lt;/em&gt;, &lt;em&gt;17&lt;/em&gt;(11), 621. doi:10.3390/md17110621</apa>
<wels>Henke, N. A.; Wendisch, V. F. (2019): Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein &lt;em&gt;Marine Drugs&lt;/em&gt;,17:(11):621</wels>
<frontiers>Henke, N. A., and Wendisch, V. F. (2019). Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein. &lt;em&gt;Marine Drugs&lt;/em&gt; 17:621.</frontiers>
<mla>Henke, Nadja Alina, and Wendisch, Volker F. “Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein”. &lt;em&gt;Marine Drugs&lt;/em&gt; 17.11 (2019): 621.</mla>
<apa_indent>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Henke, N. A., &amp;amp; Wendisch, V. F. (2019). Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein. &lt;em&gt;Marine Drugs&lt;/em&gt;, &lt;em&gt;17&lt;/em&gt;(11), 621. doi:10.3390/md17110621&lt;/div&gt;</apa_indent>
<default>Henke NA, Wendisch VF (2019) &lt;br /&gt;&lt;em&gt;Marine Drugs&lt;/em&gt; 17(11): 621.</default>
<ama>Henke NA, Wendisch VF. Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein. &lt;em&gt;Marine Drugs&lt;/em&gt;. 2019;17(11): 621.</ama>
<chicago>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Henke, Nadja Alina, and Wendisch, Volker F. 2019. “Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein”. &lt;em&gt;Marine Drugs&lt;/em&gt; 17 (11): 621.&lt;/div&gt;</chicago>
<lncs> Henke, N.A., Wendisch, V.F.: Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein. Marine Drugs. 17, : 621 (2019).</lncs>
<dgps>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Henke, N.A. &amp;amp; Wendisch, V.F. (2019). Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein. &lt;em&gt;Marine Drugs&lt;/em&gt;, &lt;em&gt;17&lt;/em&gt;(11): 621. MDPI. doi:10.3390/md17110621.&lt;/div&gt;</dgps>
<bio1>Henke NA, Wendisch VF (2019) &lt;br /&gt;Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein.&lt;br /&gt;Marine Drugs 17(11): 621.</bio1>
<angewandte-chemie>N. A.  Henke, and V. F.  Wendisch, “Improved astaxanthin production with Corynebacterium glutamicum by application of a membrane fusion protein”, &lt;em&gt;Marine Drugs&lt;/em&gt;, &lt;strong&gt;2019&lt;/strong&gt;, &lt;em&gt;17&lt;/em&gt;, : 621.</angewandte-chemie>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>2938470</recordIdentifier><recordCreationDate encoding="w3cdtf">2019-10-30T09:05:58Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2020-03-20T12:47:30Z</recordChangeDate>
</recordInfo>
</mods>